Neuroone Medical Technologies (NMTC) EBITDA Margin (2020 - 2026)
Neuroone Medical Technologies (NMTC) posted EBITDA Margin of -120.49% for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 13.18 percentage points from -107.31% a year earlier but up 5.03 percentage points from the prior quarter.
Neuroone Medical Technologies (NMTC) EBITDA Margin (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Neuroone Medical Technologies was -80.93%, down 2.22 percentage points year-over-year; for FY2025 (ended Sep 30, 2025), it was -41.46%, up 292.71 percentage points from FY2024.
- Annual EBITDA Margin has increased for three consecutive fiscal years, with a four-year change of +5649.07 percentage points (FY2021 to FY2025).
- In prior fiscal years, Neuroone Medical Technologies' EBITDA Margin was -334.18% in FY2024 (+267.94 pp), -602.12% in FY2023 (+5188.74 pp), -5790.85% in FY2022 (-100.32 pp) and -5690.54% in FY2021.
- Quarterly EBITDA Margin has run from a low of -8517.98% in fiscal Q3 2022 to a high of 60.14% in fiscal Q1 2025 over five years.
- On a year-over-year basis, EBITDA Margin increased in five of the last eight quarters, with an average year-over-year change of +118.05 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was fiscal Q3 2023, with a gain of 7969.76 percentage points; the weakest was fiscal Q1 2022, with a drop of 5277.22 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior fiscal quarters was -125.52% (Q2 2026), -56.76% (Q1 2026) and -47.68% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 267.71 Bn | 244.23 Bn | 5.13 Bn | 25.44% |
| 2 | Abbott Laboratories | 191.69 Bn | 165.56 Bn | 7.39 Bn | 20.09% |
| 3 | Danaher | 166.18 Bn | 145.83 Bn | 3.84 Bn | 30.00% |
| 4 | Intuitive Surgical | 161.07 Bn | 141.36 Bn | 2.08 Bn | 25.90% |
| 5 | Medtronic | 131.65 Bn | 96.90 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 125.25 Bn | 111.44 Bn | 4.25 Bn | 20.38% |
| 7 | Boston Scientific | 63.85 Bn | 59.29 Bn | 3.43 Bn | 23.14% |
| 8 | Edwards Lifesciences | 60.52 Bn | 43.72 Bn | 1.35 Bn | 20.05% |
| 9 | Becton Dickinson | 59.08 Bn | 56.23 Bn | 2.32 Bn | 24.62% |
| 10 | Neuroone Medical Technologies | 7.41 Mn | -7.61 Mn | 1.18 Mn | -120.49% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -120.49% |
| Mar 31, 2026 | -125.52% |
| Dec 31, 2025 | -56.76% |
| Sep 30, 2025 | -47.68% |
| Jun 30, 2025 | -107.31% |
| Mar 31, 2025 | -188.55% |
| Dec 31, 2024 | 60.14% |
| Sep 30, 2024 | -1,010.93% |
| Jun 30, 2024 | -330.69% |
| Mar 31, 2024 | -205.13% |
| Dec 31, 2023 | -340.80% |
| Sep 30, 2023 | -418.21% |
| Jun 30, 2023 | -548.22% |
| Mar 31, 2023 | -740.49% |
| Dec 31, 2022 | -1,525.99% |
| Sep 30, 2022 | -1,986.94% |
| Jun 30, 2022 | -8,517.98% |
| Mar 31, 2022 | -8,285.81% |
| Dec 31, 2021 | -8,249.86% |
| Sep 30, 2021 | -5,424.03% |
Neuroone Medical Technologies EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NMTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "NMTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NMTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();